Compounds > gentian violet

gentian violet and ER-Negative PR-Negative HER2-Negative Breast Cancer

gentian violet has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arriaga, LG; Arvizu-Espinosa, MG; de la Fuente-Jiménez, JL; Dehesa, AZ; García, JL; García-Gutiérrez, DI; García-López, EA; Garza-Navarro, MA; Herrera-Celis, J; Mitre-Aguilar, IB; Oza, G; Rodríguez-Rivas, CI; Sharma, A; Torres-Copado, A1

Other Studies

1 other study(ies) available for gentian violet and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
A Comparative and Critical Analysis for In Vitro Cytotoxic Evaluation of Magneto-Crystalline Zinc Ferrite Nanoparticles Using MTT, Crystal Violet, LDH, and Apoptosis Assay.
    International journal of molecular sciences, 2023, Aug-16, Volume: 24, Issue:16

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Gentian Violet; HEK293 Cells; Humans; Triple Negative Breast Neoplasms; Zinc

2023